Analgesic nephropathy - Continuous phenacetin consumption Factor
Last reviewed for CCPS 20 August 2008.
Investigative Documents
Medical Report - Phenacetin - Analgesic Nephropathy [MR9028]
Preliminary questions [39951]
the veteran has consumed an average of at least one gram per day of phenacetin in phenacetin-containing analgesics for a continuous period of at least one year at some time. the veteran's consumption of an average of at least one gram per day of phenacetin in phenacetin-containing analgesics for a continuous period of at least one year was materially contributed to by treatment of an illness or injury which is identifiable.39962 — the veteran has established the causal connection between continuous phenacetic consumption and VEA service for the clinical onset of analgesic nephropathy.
39963 — the veteran has established the causal connection between continuous phenacetic consumption and operational service for the clinical onset of analgesic nephropathy.
or
39964 — the veteran has established the causal connection between continuous phenacetic consumption and eligible service for the clinical onset of analgesic nephropathy.
Clinical onset and operational service [39963]
the identified illness or injury made a material contribution to the veteran's consumption of an average of at least one gram per day of phenacetin in phenacetin-containing analgesics for a continuous period of at least one year before the clinical onset of analgesic nephropathy.39132 — the identified illness or injury, which made a material contribution to the veteran's consumption of phenacetin in phenacetin-containing analgesics, is causally related to operational service.
Clinical onset and eligible service [39964]
the identified illness or injury made a material contribution to the veteran's consumption of an average of at least two grams per day of phenacetin in phenacetin-containing analgesics for a continuous period of at least one year. the identified illness or injury made a material contribution to the veteran's consumption of an average of at least two grams per day of phenacetin in phenacetin-containing analgesics for a continuous period of at least one year before the clinical onset of analgesic nephropathy.39133 — the identified illness or injury, which made a material contribution to the veteran's consumption of phenacetin in phenacetin-containing analgesics, is causally related to eligible service.